Simplified Preparation of αvβ3 Integrin-Targeted Microbubbles Based on a Clinically Available Ultrasound Contrast Agent: Validation in a Tumor-Bearing Mouse Model

Kentaro Otani, Hirohito Nishimura, Atsunori Kamiya, Mariko Harada-Shiba

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The usefulness of ultrasound molecular imaging with αvβ3 integrin-targeted microbubbles for detecting tumor angiogenesis has been demonstrated. Recently, we developed αvβ3 integrin-targeted microbubbles by modifying clinically available microbubbles (Sonazoid, Daiichi-Sankyo Pharmaceuticals, Tokyo, Japan) with a secreted glycoprotein (lactadherin). The aims of our present study were to simplify the preparation of lactadherin-bearing Sonazoid and to examine the diagnostic utility of lactadherin-bearing Sonazoid for αvβ3 integrin-expressing tumor vessels by using SK-OV-3-tumor–bearing mice. By incubating 1.2 × 107 Sonazoid microbubbles with 1.0 µg lactadherin, the complicated washing and centrifugation steps during the microbubble preparation could be omitted with no significant reduction in labeling ratio of lactadherin-bearing Sonazoid. In addition, the number of Sonazoid microbubbles accumulated in the SK-OV-3 tumor was significantly increased by modifying Sonazoid with lactadherin. Our data suggest that the lactadherin-bearing Sonazoid is an easily prepared and potentially clinically translatable targeted microbubble for αvβ3 integrin-expressing vessels.

Original languageEnglish
Pages (from-to)1063-1073
Number of pages11
JournalUltrasound in Medicine and Biology
Volume44
Issue number5
DOIs
Publication statusPublished - May 1 2018
Externally publishedYes

Fingerprint

Microbubbles
Integrins
Contrast Media
mice
tumors
preparation
vessels
Neoplasms
angiogenesis
washing
marking
Japan
Molecular Imaging
Sonazoid
Tokyo
Centrifugation
Ultrasonography
Glycoproteins

Keywords

  • Lactadherin
  • Microbubbles
  • Sonazoid
  • Tumor angiogenesis
  • Ultrasound molecular imaging

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Biophysics
  • Acoustics and Ultrasonics

Cite this

Simplified Preparation of αvβ3 Integrin-Targeted Microbubbles Based on a Clinically Available Ultrasound Contrast Agent : Validation in a Tumor-Bearing Mouse Model. / Otani, Kentaro; Nishimura, Hirohito; Kamiya, Atsunori; Harada-Shiba, Mariko.

In: Ultrasound in Medicine and Biology, Vol. 44, No. 5, 01.05.2018, p. 1063-1073.

Research output: Contribution to journalArticle

@article{9d645fe1c6cd4bf685caa9da3eb4618b,
title = "Simplified Preparation of αvβ3 Integrin-Targeted Microbubbles Based on a Clinically Available Ultrasound Contrast Agent: Validation in a Tumor-Bearing Mouse Model",
abstract = "The usefulness of ultrasound molecular imaging with αvβ3 integrin-targeted microbubbles for detecting tumor angiogenesis has been demonstrated. Recently, we developed αvβ3 integrin-targeted microbubbles by modifying clinically available microbubbles (Sonazoid, Daiichi-Sankyo Pharmaceuticals, Tokyo, Japan) with a secreted glycoprotein (lactadherin). The aims of our present study were to simplify the preparation of lactadherin-bearing Sonazoid and to examine the diagnostic utility of lactadherin-bearing Sonazoid for αvβ3 integrin-expressing tumor vessels by using SK-OV-3-tumor–bearing mice. By incubating 1.2 × 107 Sonazoid microbubbles with 1.0 µg lactadherin, the complicated washing and centrifugation steps during the microbubble preparation could be omitted with no significant reduction in labeling ratio of lactadherin-bearing Sonazoid. In addition, the number of Sonazoid microbubbles accumulated in the SK-OV-3 tumor was significantly increased by modifying Sonazoid with lactadherin. Our data suggest that the lactadherin-bearing Sonazoid is an easily prepared and potentially clinically translatable targeted microbubble for αvβ3 integrin-expressing vessels.",
keywords = "Lactadherin, Microbubbles, Sonazoid, Tumor angiogenesis, Ultrasound molecular imaging",
author = "Kentaro Otani and Hirohito Nishimura and Atsunori Kamiya and Mariko Harada-Shiba",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.ultrasmedbio.2018.01.017",
language = "English",
volume = "44",
pages = "1063--1073",
journal = "Ultrasound in Medicine and Biology",
issn = "0301-5629",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Simplified Preparation of αvβ3 Integrin-Targeted Microbubbles Based on a Clinically Available Ultrasound Contrast Agent

T2 - Validation in a Tumor-Bearing Mouse Model

AU - Otani, Kentaro

AU - Nishimura, Hirohito

AU - Kamiya, Atsunori

AU - Harada-Shiba, Mariko

PY - 2018/5/1

Y1 - 2018/5/1

N2 - The usefulness of ultrasound molecular imaging with αvβ3 integrin-targeted microbubbles for detecting tumor angiogenesis has been demonstrated. Recently, we developed αvβ3 integrin-targeted microbubbles by modifying clinically available microbubbles (Sonazoid, Daiichi-Sankyo Pharmaceuticals, Tokyo, Japan) with a secreted glycoprotein (lactadherin). The aims of our present study were to simplify the preparation of lactadherin-bearing Sonazoid and to examine the diagnostic utility of lactadherin-bearing Sonazoid for αvβ3 integrin-expressing tumor vessels by using SK-OV-3-tumor–bearing mice. By incubating 1.2 × 107 Sonazoid microbubbles with 1.0 µg lactadherin, the complicated washing and centrifugation steps during the microbubble preparation could be omitted with no significant reduction in labeling ratio of lactadherin-bearing Sonazoid. In addition, the number of Sonazoid microbubbles accumulated in the SK-OV-3 tumor was significantly increased by modifying Sonazoid with lactadherin. Our data suggest that the lactadherin-bearing Sonazoid is an easily prepared and potentially clinically translatable targeted microbubble for αvβ3 integrin-expressing vessels.

AB - The usefulness of ultrasound molecular imaging with αvβ3 integrin-targeted microbubbles for detecting tumor angiogenesis has been demonstrated. Recently, we developed αvβ3 integrin-targeted microbubbles by modifying clinically available microbubbles (Sonazoid, Daiichi-Sankyo Pharmaceuticals, Tokyo, Japan) with a secreted glycoprotein (lactadherin). The aims of our present study were to simplify the preparation of lactadherin-bearing Sonazoid and to examine the diagnostic utility of lactadherin-bearing Sonazoid for αvβ3 integrin-expressing tumor vessels by using SK-OV-3-tumor–bearing mice. By incubating 1.2 × 107 Sonazoid microbubbles with 1.0 µg lactadherin, the complicated washing and centrifugation steps during the microbubble preparation could be omitted with no significant reduction in labeling ratio of lactadherin-bearing Sonazoid. In addition, the number of Sonazoid microbubbles accumulated in the SK-OV-3 tumor was significantly increased by modifying Sonazoid with lactadherin. Our data suggest that the lactadherin-bearing Sonazoid is an easily prepared and potentially clinically translatable targeted microbubble for αvβ3 integrin-expressing vessels.

KW - Lactadherin

KW - Microbubbles

KW - Sonazoid

KW - Tumor angiogenesis

KW - Ultrasound molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=85042627212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042627212&partnerID=8YFLogxK

U2 - 10.1016/j.ultrasmedbio.2018.01.017

DO - 10.1016/j.ultrasmedbio.2018.01.017

M3 - Article

C2 - 29501282

AN - SCOPUS:85042627212

VL - 44

SP - 1063

EP - 1073

JO - Ultrasound in Medicine and Biology

JF - Ultrasound in Medicine and Biology

SN - 0301-5629

IS - 5

ER -